ADC Therapeutics S.A. (ADCT)
NYSE · Healthcare
ADC Therapeutics S.A. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 81.4M | 70.8M | 69.1M | 74.9M |
| Gross Profit | 75.6M | 64.9M | 66.5M | 71.6M |
| Profitability | ||||
| Operating Income | -121.5M | -130.7M | -166.0M | -123.3M |
| EBITDA | — | — | — | — |
| Net Income | -142.6M | -157.8M | -240.1M | -157.1M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 127M | 97M | 82M | 78M |
ADC Therapeutics S.A. Income Statement — FAQ
ADC Therapeutics S.A. (ADCT) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADCT's income statement history?
The chart and table above show ADC Therapeutics S.A.'s income statement by year and by quarter, including the growth rate.